罗欣药业
(002793)
| 流通市值：44.31亿 | | | 总市值：44.37亿 |
| 流通股本：10.86亿 | | | 总股本：10.88亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,679,620,881.67 | 1,147,454,455.61 | 582,726,187.11 | 2,273,457,651.02 |
| 营业总成本 | 1,580,861,770.29 | 1,070,756,842.95 | 559,455,929.53 | 2,515,661,813.36 |
| 其他经营收益 | | | | |
| 营业利润 | 96,296,579.44 | 78,565,537.15 | 41,914,119.7 | -300,250,506.45 |
| 利润总额 | 91,688,243.59 | 73,490,228.32 | 42,696,080.54 | -290,871,968.58 |
| 净利润 | 62,340,164.29 | 53,233,137.12 | 28,995,465.62 | -284,526,170.23 |
| 每股收益 | | | | |
| 其他综合收益 | -1,054,613.1 | -4,409,190.25 | -1,558,099.61 | 23,563,654.64 |
| 综合收益总额 | 61,285,551.19 | 48,823,946.87 | 27,437,366.01 | -260,962,515.59 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,917,528,324.39 | 1,852,715,315.65 | 1,755,627,666.59 | 1,928,943,457.17 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,710,028,402.49 | 1,761,993,655.43 | 1,813,498,977.37 | 1,796,349,021.25 |
| 资产总计 | 3,627,556,726.88 | 3,614,708,971.08 | 3,569,126,643.96 | 3,725,292,478.42 |
| 流动负债: | | | | |
| 流动负债合计 | 2,358,399,877.37 | 2,341,397,149.11 | 2,307,870,427.18 | 2,298,054,698.34 |
| 非流动负债: | | | | |
| 非流动负债合计 | 57,527,121.97 | 70,475,272.06 | 86,063,282.62 | 191,546,180.22 |
| 负债合计 | 2,415,926,999.34 | 2,411,872,421.17 | 2,393,933,709.8 | 2,489,600,878.56 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,147,170,178.44 | 1,126,280,236.68 | 1,099,803,135.44 | 1,164,035,433.35 |
| 股东权益合计 | 1,211,629,727.54 | 1,202,836,549.91 | 1,175,192,934.16 | 1,235,691,599.86 |
| 负债和股东权益合计 | 3,627,556,726.88 | 3,614,708,971.08 | 3,569,126,643.96 | 3,725,292,478.42 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,122,602,970.89 | 1,520,078,831.08 | 727,553,538.4 | 2,381,378,767.28 |
| 经营活动现金流出小计 | 1,745,534,452.65 | 1,209,871,280.07 | 585,845,559.27 | 2,128,313,089.01 |
| 经营活动产生的现金流量净额 | 377,068,518.24 | 310,207,551.01 | 141,707,979.13 | 253,065,678.27 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 192,090,517.85 | 46,420,270.57 | 38,385,737.5 | 175,805,230.9 |
| 投资活动现金流出小计 | 499,912,997.11 | 18,112,447.84 | 8,626,370.34 | 51,746,516.55 |
| 投资活动产生的现金流量净额 | -307,822,479.26 | 28,307,822.73 | 29,759,367.16 | 124,058,714.35 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,089,076,720 | 585,826,720 | 324,170,620 | 1,306,293,069.3 |
| 筹资活动现金流出小计 | 1,150,698,560.27 | 597,111,016 | 294,387,956.34 | 1,641,312,475.75 |
| 筹资活动产生的现金流量净额 | -61,621,840.27 | -11,284,296 | 29,782,663.66 | -335,019,406.45 |
| 汇率变动对现金及现金等价物的影响 | -1,313,099.99 | -5,024,304.35 | -1,523,243.08 | -1,229,131.41 |
| 现金及现金等价物净增加额 | 6,311,098.72 | 322,206,773.39 | 199,726,766.87 | 40,875,854.76 |
| 期末现金及现金等价物余额 | 336,576,368.9 | 652,472,043.57 | 528,974,636.95 | 330,265,270.18 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 322,206,773.39 | - | 40,875,854.76 |